Chinese (SSE) Drug Retail Industry Analysis

UpdatedSep 02, 2026

DataAggregated Company Financials

Companies9

7D-1.6%
3M7.4%
1Y-7.4%
YTDn/a

Over the last 7 days, the Drug Retail industry has dropped 1.6%, driven by a pullback from Yifeng Pharmacy Chain of 4.5%. The industry has fallen 7.4% in the last year. Earnings are forecast to grow by 15% annually.

Industry Valuation and Performance

Has the Chinese Drug Retail Industry valuation changed over the past few years?

Date	Market Cap	Revenue	Earnings	PE	Absolute PE	PS
Wed, 02 Sep 2026	CN¥84.1b	CN¥124.0b	CN¥4.3b	23.7x	19.4x	0.7x
Fri, 31 Jul 2026	CN¥82.8b	CN¥122.8b	CN¥4.2b	24.2x	19.7x	0.7x
Sun, 28 Jun 2026	CN¥70.0b	CN¥122.8b	CN¥4.2b	20.7x	16.6x	0.6x
Tue, 26 May 2026	CN¥80.3b	CN¥122.8b	CN¥4.2b	23.5x	19.1x	0.7x
Thu, 23 Apr 2026	CN¥88.4b	CN¥121.3b	CN¥3.6b	24.9x	24.6x	0.7x
Sat, 21 Mar 2026	CN¥88.7b	CN¥121.2b	CN¥3.6b	24.9x	24.7x	0.7x
Mon, 16 Feb 2026	CN¥93.8b	CN¥121.2b	CN¥3.6b	27.1x	26.1x	0.8x
Wed, 14 Jan 2026	CN¥95.5b	CN¥121.2b	CN¥3.6b	28.3x	26.5x	0.8x
Fri, 12 Dec 2025	CN¥86.3b	CN¥121.2b	CN¥3.6b	28x	24x	0.7x
Sun, 09 Nov 2025	CN¥89.8b	CN¥121.2b	CN¥3.6b	30.5x	25x	0.7x
Tue, 07 Oct 2025	CN¥87.3b	CN¥120.6b	CN¥3.3b	30.1x	26.2x	0.7x
Thu, 04 Sep 2025	CN¥90.4b	CN¥120.6b	CN¥3.2b	29.9x	28.1x	0.7x
Sat, 02 Aug 2025	CN¥93.2b	CN¥120.4b	CN¥3.3b	31.8x	28.6x	0.8x
Mon, 30 Jun 2025	CN¥91.5b	CN¥120.4b	CN¥3.3b	32.5x	28.1x	0.8x
Wed, 28 May 2025	CN¥96.5b	CN¥120.4b	CN¥3.3b	31.6x	29.6x	0.8x
Fri, 25 Apr 2025	CN¥93.2b	CN¥121.0b	CN¥3.9b	23.1x	24x	0.8x
Sun, 23 Mar 2025	CN¥88.1b	CN¥121.0b	CN¥3.9b	20x	22.6x	0.7x
Tue, 18 Feb 2025	CN¥88.0b	CN¥121.0b	CN¥3.9b	20x	22.5x	0.7x
Thu, 16 Jan 2025	CN¥81.0b	CN¥121.0b	CN¥3.9b	18.7x	20.7x	0.7x
Sat, 14 Dec 2024	CN¥94.3b	CN¥121.0b	CN¥3.9b	21x	24.1x	0.8x
Mon, 11 Nov 2024	CN¥95.1b	CN¥121.0b	CN¥3.9b	21.4x	24.4x	0.8x
Wed, 09 Oct 2024	CN¥96.5b	CN¥119.6b	CN¥4.3b	22.2x	22.3x	0.8x
Fri, 06 Sep 2024	CN¥78.2b	CN¥119.6b	CN¥4.3b	23.2x	18.2x	0.7x
Sun, 04 Aug 2024	CN¥74.8b	CN¥118.4b	CN¥4.8b	17x	15.6x	0.6x
Tue, 02 Jul 2024	CN¥88.4b	CN¥118.4b	CN¥4.8b	20.9x	18.4x	0.7x
Thu, 30 May 2024	CN¥122.9b	CN¥118.4b	CN¥4.8b	25.3x	25.6x	1x
Sat, 27 Apr 2024	CN¥118.8b	CN¥114.9b	CN¥5.2b	21.4x	22.9x	1x
Mon, 25 Mar 2024	CN¥112.4b	CN¥115.1b	CN¥5.3b	20.9x	21.4x	1x
Wed, 21 Feb 2024	CN¥118.5b	CN¥115.9b	CN¥5.8b	21.5x	20.4x	1x
Fri, 19 Jan 2024	CN¥124.9b	CN¥116.0b	CN¥5.7b	22.1x	21.8x	1.1x
Sun, 17 Dec 2023	CN¥123.5b	CN¥116.0b	CN¥5.7b	22.2x	21.5x	1.1x
Tue, 14 Nov 2023	CN¥128.4b	CN¥115.4b	CN¥5.7b	22.5x	22.6x	1.1x
Thu, 12 Oct 2023	CN¥117.4b	CN¥113.6b	CN¥5.7b	22.5x	20.7x	1x
Sat, 09 Sep 2023	CN¥117.6b	CN¥113.6b	CN¥5.7b	23.2x	20.7x	1x

Price to Earnings Ratio

20.7x

Sat, 09 Sep 2023

Current Industry PE

Investors are pessimistic on the Chinese Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.

The industry is trading at a PE ratio of 19.4x which is lower than its 3-year average PE of 22.8x.

The industry is trading close to its 3-year average PS ratio of 0.81x.

Past Earnings Growth

The earnings for companies in the Drug Retail industry have declined 8.5% per year over the last three years.
Meanwhile revenues for these companies have grown 2.9% per year.
This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does Chinese Drug Retail compare with similar industries?


CN Market	1.75%
Consumer Staples	1.36%
Food and Staples Retail	2.69%
Drug Retail	-1.63%
Food Distributors	10.26%
Food Retail	5.10%
Big Box Super Stores	3.81%

Industry PEThere are no additional sub-industries under this industry.

Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

	Company	Last Price	7D	1Y	Valuation
	603883 LBX Pharmacy Chain	CN¥13.16	0.9% +CN¥91.1m	-23.9%	PE23.2x
	300937 Sichuan Hezong Medicine Easy-to-buy Pharmaceutical	CN¥25.53	1.5% +CN¥36.4m	-7.9%	PS0.5x